Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles

Extract: Clinical trials of the triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy elexacaftor/tezacaftor/ivacaftor (ETI) demonstrated unprecedented clinical benefits including improvements in lung function, respiratory symptoms and nutritional outcomes i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stahl, Mirjam (VerfasserIn) , Dohna, Martha (VerfasserIn) , Gräber, Simon Y. (VerfasserIn) , Sommerburg, Olaf (VerfasserIn) , Renz, Diane M. (VerfasserIn) , Pallenberg, Sophia Theres (VerfasserIn) , Voskrebenzev, Andreas (VerfasserIn) , Schütz, Katharina (VerfasserIn) , Hansen, Gesine (VerfasserIn) , Doellinger, Felix (VerfasserIn) , Steinke, Eva (VerfasserIn) , Thee, Stephanie (VerfasserIn) , Röhmel, Jobst (VerfasserIn) , Barth, Sandra (VerfasserIn) , Rückes-Nilges, Claudia (VerfasserIn) , Berges, Julian (VerfasserIn) , Hämmerling, Susanne Hedwig (VerfasserIn) , Wielpütz, Mark Oliver (VerfasserIn) , Naehrlich, Lutz (VerfasserIn) , Vogel-Claussen, Jens (VerfasserIn) , Tümmler, Burkhard (VerfasserIn) , Mall, Marcus A. (VerfasserIn) , Dittrich, Anna-Maria (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 September 2024
In: The European respiratory journal
Year: 2024, Jahrgang: 64, Heft: 3, Pages: 1-13
ISSN:1399-3003
DOI:10.1183/13993003.00004-2024
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1183/13993003.00004-2024
Verlag, kostenfrei, Volltext: https://publications.ersnet.org/content/erj/64/3/2400004
Volltext
Verfasserangaben:Mirjam Stahl, Martha Dohna, Simon Y. Graeber, Olaf Sommerburg, Diane M. Renz, Sophia T. Pallenberg, Andreas Voskrebenzev, Katharina Schütz, Gesine Hansen, Felix Doellinger, Eva Steinke, Stephanie Thee, Jobst Röhmel, Sandra Barth, Claudia Rückes-Nilges, Julian Berges, Susanne Hämmerling, Mark O. Wielpütz, Lutz Naehrlich, Jens Vogel-Claussen, Burkhard Tümmler, Marcus A. Mall and Anna-Maria Dittrich

MARC

LEADER 00000caa a2200000 c 4500
001 1928493114
003 DE-627
005 20250618122031.0
007 cr uuu---uuuuu
008 250617s2024 xx |||||o 00| ||eng c
024 7 |a 10.1183/13993003.00004-2024  |2 doi 
035 |a (DE-627)1928493114 
035 |a (DE-599)KXP1928493114 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stahl, Mirjam  |e VerfasserIn  |0 (DE-588)1050007778  |0 (DE-627)783125836  |0 (DE-576)404265367  |4 aut 
245 1 0 |a Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles  |c Mirjam Stahl, Martha Dohna, Simon Y. Graeber, Olaf Sommerburg, Diane M. Renz, Sophia T. Pallenberg, Andreas Voskrebenzev, Katharina Schütz, Gesine Hansen, Felix Doellinger, Eva Steinke, Stephanie Thee, Jobst Röhmel, Sandra Barth, Claudia Rückes-Nilges, Julian Berges, Susanne Hämmerling, Mark O. Wielpütz, Lutz Naehrlich, Jens Vogel-Claussen, Burkhard Tümmler, Marcus A. Mall and Anna-Maria Dittrich 
246 3 0 |a elexacaftor tezacaftor ivacaftor 
264 1 |c 5 September 2024 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.06.2025 
520 |a Extract: Clinical trials of the triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy elexacaftor/tezacaftor/ivacaftor (ETI) demonstrated unprecedented clinical benefits including improvements in lung function, respiratory symptoms and nutritional outcomes in patients with cystic fibrosis (CF) aged ≥2 years with at least one copy of the F508del allele [1-11]. Despite the emergence of highly effective CFTR modulator therapy, chronic progressive lung disease remains the main cause of morbidity and mortality in patients with CF; however, early intervention with CFTR-directed therapeutics in children with CF now provides an opportunity to delay or even prevent irreversible lung damage. Because of the limited sensitivity of percentage predicted forced expiratory volume in 1 s (FEV<sub>1</sub>) to capture response to therapy in CF children with preserved spirometry [12, 13], more sensitive outcome measures such as multiple-breath washout (MBW) and lung imaging by computed tomography (CT) and magnetic resonance imaging (MRI) have been established [14-25]. A number of studies demonstrated that the LCI derived from MBW is sensitive to detect response to therapeutic interventions including CFTR modulators in children with CF with normal spirometry [9-15, 18]. 
700 1 |a Dohna, Martha  |e VerfasserIn  |4 aut 
700 1 |a Gräber, Simon Y.  |d 1985-  |e VerfasserIn  |0 (DE-588)1056936177  |0 (DE-627)794247199  |0 (DE-576)412922029  |4 aut 
700 1 |a Sommerburg, Olaf  |d 1967-  |e VerfasserIn  |0 (DE-588)172907470  |0 (DE-627)69783543X  |0 (DE-576)133762270  |4 aut 
700 1 |a Renz, Diane M.  |e VerfasserIn  |4 aut 
700 1 |a Pallenberg, Sophia Theres  |d 1994-  |e VerfasserIn  |0 (DE-588)1245887645  |0 (DE-627)1777519772  |4 aut 
700 1 |a Voskrebenzev, Andreas  |d 1987-  |e VerfasserIn  |0 (DE-588)1156418712  |0 (DE-627)1019245697  |0 (DE-576)502172584  |4 aut 
700 1 |a Schütz, Katharina  |e VerfasserIn  |4 aut 
700 1 |a Hansen, Gesine  |d 1965-  |e VerfasserIn  |0 (DE-588)123107334  |0 (DE-627)082351414  |0 (DE-576)293558876  |4 aut 
700 1 |a Doellinger, Felix  |e VerfasserIn  |4 aut 
700 1 |a Steinke, Eva  |e VerfasserIn  |0 (DE-588)1265220352  |0 (DE-627)181426938X  |4 aut 
700 1 |a Thee, Stephanie  |e VerfasserIn  |4 aut 
700 1 |a Röhmel, Jobst  |e VerfasserIn  |4 aut 
700 1 |a Barth, Sandra  |e VerfasserIn  |4 aut 
700 1 |a Rückes-Nilges, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Berges, Julian  |d 1988-  |e VerfasserIn  |0 (DE-588)1215872615  |0 (DE-627)1727029070  |4 aut 
700 1 |a Hämmerling, Susanne Hedwig  |d 1978-  |e VerfasserIn  |0 (DE-588)13711902X  |0 (DE-627)694895296  |0 (DE-576)302153942  |4 aut 
700 1 |a Wielpütz, Mark Oliver  |d 1982-  |e VerfasserIn  |0 (DE-588)139999752  |0 (DE-627)614754682  |0 (DE-576)314127046  |4 aut 
700 1 |a Naehrlich, Lutz  |e VerfasserIn  |4 aut 
700 1 |a Vogel-Claussen, Jens  |e VerfasserIn  |4 aut 
700 1 |a Tümmler, Burkhard  |d 1952-  |e VerfasserIn  |0 (DE-588)131336797  |0 (DE-627)50737259X  |0 (DE-576)298414937  |4 aut 
700 1 |a Mall, Marcus A.  |d 1975-  |e VerfasserIn  |0 (DE-588)115507795  |0 (DE-627)691370532  |0 (DE-576)28992152X  |4 aut 
700 1 |a Dittrich, Anna-Maria  |d 1973-  |e VerfasserIn  |0 (DE-588)122927362  |0 (DE-627)706094573  |0 (DE-576)293479569  |4 aut 
773 0 8 |i Enthalten in  |t The European respiratory journal  |d Lausanne : ERS, 1988  |g 64(2024), 3, Artikel-ID 2400004, Seite 1-13  |h Online-Ressource  |w (DE-627)306646803  |w (DE-600)1499101-9  |w (DE-576)091142504  |x 1399-3003  |7 nnas  |a Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles 
773 1 8 |g volume:64  |g year:2024  |g number:3  |g elocationid:2400004  |g pages:1-13  |g extent:13  |a Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles 
856 4 0 |u https://doi.org/10.1183/13993003.00004-2024  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://publications.ersnet.org/content/erj/64/3/2400004  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250617 
993 |a Article 
994 |a 2024 
998 |g 139999752  |a Wielpütz, Mark Oliver  |m 139999752:Wielpütz, Mark Oliver  |d 910000  |d 911400  |d 50000  |e 910000PW139999752  |e 911400PW139999752  |e 50000PW139999752  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 18 
998 |g 13711902X  |a Hämmerling, Susanne Hedwig  |m 13711902X:Hämmerling, Susanne Hedwig  |d 910000  |d 910500  |e 910000PH13711902X  |e 910500PH13711902X  |k 0/910000/  |k 1/910000/910500/  |p 17 
998 |g 1215872615  |a Berges, Julian  |m 1215872615:Berges, Julian  |d 910000  |d 910500  |e 910000PB1215872615  |e 910500PB1215872615  |k 0/910000/  |k 1/910000/910500/  |p 16 
998 |g 172907470  |a Sommerburg, Olaf  |m 172907470:Sommerburg, Olaf  |d 910000  |d 910500  |d 50000  |e 910000PS172907470  |e 910500PS172907470  |e 50000PS172907470  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 4 
998 |g 1050007778  |a Stahl, Mirjam  |m 1050007778:Stahl, Mirjam  |d 50000  |e 50000PS1050007778  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1928493114  |e 473504132X 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1928493114","id":{"doi":["10.1183/13993003.00004-2024"],"eki":["1928493114"]},"name":{"displayForm":["Mirjam Stahl, Martha Dohna, Simon Y. Graeber, Olaf Sommerburg, Diane M. Renz, Sophia T. Pallenberg, Andreas Voskrebenzev, Katharina Schütz, Gesine Hansen, Felix Doellinger, Eva Steinke, Stephanie Thee, Jobst Röhmel, Sandra Barth, Claudia Rückes-Nilges, Julian Berges, Susanne Hämmerling, Mark O. Wielpütz, Lutz Naehrlich, Jens Vogel-Claussen, Burkhard Tümmler, Marcus A. Mall and Anna-Maria Dittrich"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Stahl, Mirjam","given":"Mirjam","family":"Stahl"},{"display":"Dohna, Martha","roleDisplay":"VerfasserIn","given":"Martha","family":"Dohna","role":"aut"},{"family":"Gräber","display":"Gräber, Simon Y.","roleDisplay":"VerfasserIn","given":"Simon Y.","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Sommerburg, Olaf","given":"Olaf","family":"Sommerburg"},{"family":"Renz","roleDisplay":"VerfasserIn","display":"Renz, Diane M.","given":"Diane M.","role":"aut"},{"given":"Sophia Theres","roleDisplay":"VerfasserIn","display":"Pallenberg, Sophia Theres","family":"Pallenberg","role":"aut"},{"display":"Voskrebenzev, Andreas","roleDisplay":"VerfasserIn","given":"Andreas","family":"Voskrebenzev","role":"aut"},{"role":"aut","display":"Schütz, Katharina","roleDisplay":"VerfasserIn","given":"Katharina","family":"Schütz"},{"role":"aut","given":"Gesine","roleDisplay":"VerfasserIn","display":"Hansen, Gesine","family":"Hansen"},{"family":"Doellinger","display":"Doellinger, Felix","roleDisplay":"VerfasserIn","given":"Felix","role":"aut"},{"role":"aut","given":"Eva","roleDisplay":"VerfasserIn","display":"Steinke, Eva","family":"Steinke"},{"role":"aut","family":"Thee","roleDisplay":"VerfasserIn","given":"Stephanie","display":"Thee, Stephanie"},{"role":"aut","display":"Röhmel, Jobst","roleDisplay":"VerfasserIn","given":"Jobst","family":"Röhmel"},{"role":"aut","family":"Barth","given":"Sandra","roleDisplay":"VerfasserIn","display":"Barth, Sandra"},{"role":"aut","display":"Rückes-Nilges, Claudia","roleDisplay":"VerfasserIn","given":"Claudia","family":"Rückes-Nilges"},{"family":"Berges","roleDisplay":"VerfasserIn","given":"Julian","display":"Berges, Julian","role":"aut"},{"family":"Hämmerling","roleDisplay":"VerfasserIn","given":"Susanne Hedwig","display":"Hämmerling, Susanne Hedwig","role":"aut"},{"family":"Wielpütz","display":"Wielpütz, Mark Oliver","roleDisplay":"VerfasserIn","given":"Mark Oliver","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Lutz","display":"Naehrlich, Lutz","family":"Naehrlich","role":"aut"},{"role":"aut","display":"Vogel-Claussen, Jens","roleDisplay":"VerfasserIn","given":"Jens","family":"Vogel-Claussen"},{"role":"aut","display":"Tümmler, Burkhard","roleDisplay":"VerfasserIn","given":"Burkhard","family":"Tümmler"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Marcus A.","display":"Mall, Marcus A.","family":"Mall"},{"family":"Dittrich","roleDisplay":"VerfasserIn","given":"Anna-Maria","display":"Dittrich, Anna-Maria","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles","title":"Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles"}],"origin":[{"dateIssuedDisp":"5 September 2024","dateIssuedKey":"2024"}],"note":["Gesehen am 17.06.2025"],"relHost":[{"note":["Gesehen am 25.04.2025","Fortsetzung der Druck-Ausgabe"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del allelesThe European respiratory journal","language":["eng"],"origin":[{"dateIssuedDisp":"1988-","publisher":"ERS ; Munksgaard","publisherPlace":"Lausanne ; Copenhagen","dateIssuedKey":"1988"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"European Respiratory Society","role":"isb"}],"part":{"extent":"13","text":"64(2024), 3, Artikel-ID 2400004, Seite 1-13","volume":"64","pages":"1-13","year":"2024","issue":"3"},"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"official journal of the European Society for Clinical Respiratory Physiology : ERJ"},{"title":"ERJ"}],"title":[{"subtitle":"flagship scientific journal of ERS","title":"The European respiratory journal","title_sort":"European respiratory journal"}],"recId":"306646803","id":{"issn":["1399-3003"],"eki":["306646803"],"zdb":["1499101-9"]},"pubHistory":["1.1988 -"],"name":{"displayForm":["European Respiratory Society"]}}],"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"language":["eng"]} 
SRT |a STAHLMIRJAIMPACTOFEL5202